161 related articles for article (PubMed ID: 15043196)
1. Gene therapy for prostate cancer bone metastasis. Gene therapy targeting bone metastasis.
Hsieh CL; Kubo H; Chung LW
Cancer Treat Res; 2004; 118():231-90. PubMed ID: 15043196
[No Abstract] [Full Text] [Related]
2. "Gotta Catch 'em All", or Do We? Pokemet Approach to Metastatic Prostate Cancer.
Murphy DG; Sweeney CJ; Tombal B
Eur Urol; 2017 Jul; 72(1):1-3. PubMed ID: 28283344
[TBL] [Abstract][Full Text] [Related]
3. Are we trumping bone disease in prostate cancer?
Slovin SF
Oncology (Williston Park); 2011 Dec; 25(14):1390, 1393. PubMed ID: 22329190
[No Abstract] [Full Text] [Related]
4. A dual-targeted lentiviral vector homing in on prostate bone metastases.
Hu Y; Stout D; Wu L
Mol Ther; 2007 Nov; 15(11):1906-8. PubMed ID: 17948046
[No Abstract] [Full Text] [Related]
5. Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.
Toneri M; Miwa S; Zhang Y; Hu C; Yano S; Matsumoto Y; Bouvet M; Nakanishi H; Hoffman RM; Zhao M
Oncotarget; 2015 Oct; 6(31):31335-43. PubMed ID: 26431498
[TBL] [Abstract][Full Text] [Related]
6. Stromal targeted therapy in bone metastatic prostate cancer: promise delivered.
Sartor O; Goeckeler W; Bruland O
Asian J Androl; 2011 Nov; 13(6):783-4. PubMed ID: 21857688
[No Abstract] [Full Text] [Related]
7. [Current diagnosis and the multidisciplinary approach to the treatment of bone metastases in patients with prostate cancer].
Satoh T; Ishiyama H
Nihon Rinsho; 2016 Jan; 74(1):129-36. PubMed ID: 26793893
[TBL] [Abstract][Full Text] [Related]
8. [Radium-223 for the treatment of bone metastasis of prostate cancer].
Xu XF; Wei ZF; Zhang ZY
Zhonghua Nan Ke Xue; 2017 Jan; 23(1):78-81. PubMed ID: 29658243
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
Corkum MT
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):492-493. PubMed ID: 28581385
[No Abstract] [Full Text] [Related]
10. [Treatment strategy for prostate cancer].
Kakehi Y
Nihon Rinsho; 2002 Dec; 60 Suppl 11():170-6. PubMed ID: 12599566
[No Abstract] [Full Text] [Related]
11. Prostate cancer with bone metastasis in Beijing: an observational study of prevalence, hospital visits and treatment costs using data from an administrative claims database.
Zhuo L; Cheng Y; Pan Y; Zong J; Sun W; Xu L; Soriano-Gabarró M; Song Y; Lu J; Zhan S
BMJ Open; 2019 Jun; 9(6):e028214. PubMed ID: 31230019
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases: improving the therapeutic index.
Scher HI; Chung LW
Semin Oncol; 1994 Oct; 21(5):630-56. PubMed ID: 7939753
[No Abstract] [Full Text] [Related]
13. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapeutic strategies for prostate cancer.
Nelson WG
Clin Adv Hematol Oncol; 2005 Aug; 3(8):619-21. PubMed ID: 16167046
[No Abstract] [Full Text] [Related]
15. Prostate cancer gene therapy clinical trials.
Freytag SO; Stricker H; Movsas B; Kim JH
Mol Ther; 2007 Jun; 15(6):1042-52. PubMed ID: 17406342
[TBL] [Abstract][Full Text] [Related]
16. Bone metastases in prostate cancer: a targeted approach.
Storey JA; Torti FM
Curr Opin Oncol; 2007 May; 19(3):254-8. PubMed ID: 17414645
[TBL] [Abstract][Full Text] [Related]
17. Management options for painful carcinoma of the prostate.
Chisholm GD; Rana A; Howard GC
Semin Oncol; 1993 Jun; 20(3 Suppl 2):34-7. PubMed ID: 7684864
[No Abstract] [Full Text] [Related]
18. [Bone metastasis from prostate cancer].
Uemura M; Nonomura N
Clin Calcium; 2014 Aug; 24(8):1169-75. PubMed ID: 25065868
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy in prostate cancer: past, present and future.
Shirakawa T; Fujisawa M; Gotoh A
Front Biosci; 2008 Jan; 13():2115-9. PubMed ID: 17981696
[TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
